GNS

Chr 12AR

glucosamine (N-acetyl)-6-sulfatase

Also known as: G6S

This gene encodes a lysosomal enzyme that catabolizes heparin, heparan sulfate, and keratan sulfate. Mutations cause mucopolysaccharidosis type IIID (Sanfilippo D syndrome), the rarest subtype of Sanfilippo syndrome, through autosomal recessive inheritance. Enzyme deficiency leads to accumulation of undegraded substrate in lysosomes, resulting in progressive neurodegeneration.

GeneReviewsOMIMResearchSummary from RefSeq, OMIM, UniProt, Mechanism
LOFmechanismARLOEUF 0.611 OMIM phenotype
Clinical SummaryGNS
🧬
Gene-Disease Validity (ClinGen)
mucopolysaccharidosis type 3D · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
46 unique Pathogenic / Likely Pathogenic· 122 VUS of 400 total submissions
📖
GeneReview available — GNS
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
0.61LOEUF
pLI 0.001
Z-score 3.22
OE 0.37 (0.230.61)
Tolerant

Typical tolerance to LoF variation

Missense Constraint
1.37Z-score
OE missense 0.78 (0.700.87)
234 obs / 301.1 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.37 (0.230.61)
00.351.4
Missense OE0.78 (0.700.87)
00.61.4
Synonymous OE0.96
01.21.6
LoF obs/exp: 11 / 30.1Missense obs/exp: 234 / 301.1Syn Z: 0.33
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveGNS-related mucopolysaccharidosisLOFAR

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.6937th %ile
GOF
0.5955th %ile
LOF
0.3261th %ile

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

400 submitted variants in ClinVar

Classification Summary

Pathogenic25
Likely Pathogenic21
VUS122
Likely Benign219
Benign2
Conflicting1
25
Pathogenic
21
Likely Pathogenic
122
VUS
219
Likely Benign
2
Benign
1
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
22
0
3
0
25
Likely Pathogenic
18
1
2
0
21
VUS
3
102
9
8
122
Likely Benign
0
2
112
105
219
Benign
0
0
2
0
2
Conflicting
1
Total43105128113390

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

GNS · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →